CompletedNCT06091163
Official study titleA Randomised Controlled Trial Evaluating the Efficacy and Mechanisms of a Ketogenic Diet as an Adjunctive Treatment for People With Treatment-resistant Depression
This study has finished and is no longer accepting participants.
In OxfordDepressionBehavioural studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- University of Oxford (University)
TerminatedNCT06682299
Official study titleTransitioning From Maintenance ECT to Maintenance TMS in Treatment Resistant Depression
This study ended early.
In LexingtonDepressionDevice studyAges 18–65
- Countries
- United States
- Sponsor
- Austin Messner
Active Not RecruitingNCT07164755
Official study titleMeasurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.
This study is no longer accepting new participants.
In LondonDepressionObservational studyAges 25–80
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
CompletedNCT06357832
What is this study about?This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including TuscaloosaDepressionDevice studyAges 22–68
- Countries
- United States, India, Israel
- Sponsor
- Brainsway
CompletedNCT07274917
Official study titleSafety and Efficacy of Low-Dose Stereotactic Radiotherapy Targeting the Subgenual Anterior Cingulate Cortex for Treatment-Resistant Depression: Study Protocol for a Dose-Exploratory, Parallel-Controlled Trial
This study has finished and is no longer accepting participants.
In BeijingDepressionDevice studyAges 18–50
- Countries
- China
- Sponsor
- Capital Medical University
CompletedNCT05870501
Official study titleSynaptic Imaging and Brain Network Activity Following Ketamine in Treatment Resistant Depression
This study has finished and is no longer accepting participants.
In LondonDepression, BipolarityMedication studyAges 18–55
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
CompletedNCT04979910
Official study titleAn Experimental Therapeutics Study of a Monoclonal Antibody Against Interleukin 17A in Patients With Treatment-Resistant Depression
This study has finished and is no longer accepting participants.
In New YorkDepressionMedication studyAges 18–70
- Countries
- United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
CompletedNCT03207282
This study has finished and is no longer accepting participants.
Multiple locations, including Buenos AiresDepressionObservational studyAges 18+
- Countries
- Argentina, Brazil, Colombia, + 1 other
- Sponsor
- Janssen-Cilag, S.A.
CompletedNCT03373253
This study has finished and is no longer accepting participants.
Multiple locations, including BilzenDepressionObservational studyAges 18–74
- Countries
- United Kingdom, Belgium, Germany, + 4 others
- Sponsor
- Janssen-Cilag Ltd.